Should immunotherapy be the standard of care for patients with glioblastoma?HealioGlioblastoma continues to be one of the most aggressive malignancies, with no profound breakthroughs despite incremental improvements. Patients and physicians are despera… Continue reading
TVGrapevine.comPURE GENIUS LIFT ME UPTVGrapevine.comAlso, when a graffiti artist with a clotting disorder falls from a bridge, Walter, Malik and Zoe attempt to use suspended animation to stop his internal bleeding. And Walter is put in an awkward posit… Continue reading
University of California |
CRISPR research institute expands into agriculture, microbiology
University of California An initiative launched two years ago by UC Berkeley and UC San Francisco to use CRISPR-Cas9 gene editing to develop new disease therapies is expanding into research on the planet’s major crops and poorly understood microbiomes, with plans to invest … |
SBS |
Stem cell researcher Alan Mackay-Sim named 2017 Australian of the Year
SBS Professor Mackay-Sim has also served as the director of the National Centre for Adult Stem Cell Research for a decade, and championed the use of stem cells to try and better understand brain disorders such as schizophrenia and Parkinson’s disease. |
SBS |
Stem cell researcher Alan Mackay-Sim named 2017 Australian of the Year
SBS Professor Mackay-Sim has also served as the director of the National Centre for Adult Stem Cell Research for a decade, and championed the use of stem cells to try and better understand brain disorders such as schizophrenia and Parkinson’s disease. |
The Australian |
Australian of the year 2017: Alan Mackay-Sim, stem cell scientist, honoured
The Australian He said he hoped 2017 would offer the opportunity to talk about the importance of research on spinal cord and rare brain diseases, as well as the therapeutic futures of stem cells and cell transplantation, which were undreamed of 20 years ago. “We must … |
The Australian |
Australian of the year 2017: Alan Mackay-Sim, stem cell scientist, honoured
The Australian He said he hoped 2017 would offer the opportunity to talk about the importance of research on spinal cord and rare brain diseases, as well as the therapeutic futures of stem cells and cell transplantation, which were undreamed of 20 years ago. “We must … |